Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | December 15, 2011

Mammography’s Looming Dose War

By Greg Freiherr

As the dose wars in computed tomography (CT) draw to a close, a new one approaches, this one in mammography. The surprise should not be that this war is coming, but that it is taking so long to get here.

Mammography is the only imaging exam widely performed to screen apparently healthy people. It exposes them to ionizing radiation that, if administered in substantial quantities, can cause the very disease for which they are being screened. And it does so not once or twice, but annually for 30 or more years, per guidelines developed by the American Cancer Society (, with the understanding that the risk of cancer from radiation exposure increases with cumulative dose.

Yet, in the past, when questions about the benefit of such repetitive screening were raised, they were immediately and soundly rebuked by women’s health leaders who defended screening as a major, if not the primary, reason for declining deaths due to breast cancer.  Then why now do I believe dose will become an issue? Because the technology to reduce dose is finally available in the United States  – and being aggressively marketed on its ability to significantly cut patient radiation dose.

This product – Philips’ Microdose mammography product – like so much about mammography and radiation dose, is steeped in irony. It is not new.  It has been sold for years in Europe. But Microdose entered the U.S. only this fall after Philips Healthcare acquired Sectra’s mammography modality business operations.

Three months after this deal was final, during the RSNA annual meeting in November, the ability of this product to cut patient radiation dose was ballyhooed on the exhibit floor of the McCormick Center, on television, even on the sides of buses ferrying radiologists to and from the meeting. The message was inescapable. And it will become so again in the year ahead.

Much like what happened in CT, all the vendors of mammography equipment will have to climb onboard this bandwagon and they will have to do so quickly. They cannot cede the high ground of digital mammography to newcomer Philips, nor can they risk appearing unsympathetic to concerns about radiation dose, when tens of millions of American women undergo mammography every year.

With this, we can expect a new vernacular for the modality, one reliant on the use of “low,” “optimized,” “minimum” and “efficient” as  descriptors of dose administered by mammography equipment. Vendors will use several, possibly all, these descriptors in the same paragraph, if not the same sentence to define their products.

When that happens, it will be a sure sign that this new war has begun.

Related Content

breast MRI, additional multicentric cancers, mammography, Chiara Iacconi, Radiology journal
News | MRI Breast | November 25, 2015
Additional breast cancers found with magnetic resonance imaging (MRI) are sometimes larger and potentially more...
News | RSNA 2015 | November 25, 2015
November 25, 2015 – Teledyne DALSA, a Teledyne Technologies company and global leader in digital X-Ray image sensing
Medic Vision, SafeCT-29, XR-29 compliance, CT systems, RSNA 2015

Image courtesy of Siemens

Technology | Computed Tomography (CT) | November 24, 2015
Medic Vision Imaging Solutions Ltd. announced the introduction of SafeCT-29. Designed to be computed tomography (CT)-...

The FDA said there is little need for hard copies of mammograms in the digital age, but it still provides guidelines for quality assurance if printers are maintained at breast imaging centers. 

Feature | Breast Imaging | November 24, 2015 | Dave Fornell
November 24, 2015 — Over the past 20 years, there has been significant evolution in mammography, with the shift from
Viztek, Exa Mammo Viewer, breast imaging management workstation, RSNA 2015

Image courtesy of Viztek

Technology | Mammography Reporting Software | November 24, 2015
Viztek, a Konica Minolta Company, will showcase the Exa Mammo Viewer – a PACS-neutral, breast imaging management...
Three Palm Software, WorkstationOne breast imaging workstation, version 1.8.0, RSNA 2015

Image courtesy of Three Palm Software

Technology | Mammography Reporting Software | November 23, 2015
Three Palm Software announced the release of the 1.8.0 version of its breast imaging workstation, WorkstationOne. This...
Unfors Raysafe, RSNA 2015, Low Dose Hero game, radiation exposure, i2 badge

Raysafe i2 image courtesy of Unfors RaySafe

News | Radiation Dose Management | November 19, 2015
Unfors RaySafe Inc., a Fluke Biomedical company, will be showcasing the game Low Dose Hero during the Radiological...
News | Clinical Study | November 19, 2015
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing
Gamma Medica, LumaGEM MBI, RSNA 2015, molecular breast imaging

Image courtesy of Gamma Medica Inc.

News | Breast Imaging | November 18, 2015
At this year's Radiological Society of North America (RSNA) annual meeting, Gamma Medica Inc. invites congress...
GE Healthcare, molecular imaging, PET/CT, Discovery IQ, Discovery NM/CT 670 Pro, RSNA 2015

Discovery IQ PET/CT image courtesy of GE Healthcare

News | Nuclear Imaging | November 16, 2015
GE Healthcare’s Molecular Imaging business will showcase the Discovery IQ positron emission tomography/computed...
Overlay Init